Be the first to know

Never miss an update from Polynovo. Did you know that during reporting season, the announcements from ASX:PNV often move the market?

Polynovo (ASX:PNV) Company Logo

By joining StockLight, you agree to our Terms & Conditions and Privacy Policy
Create Alert Follow PNV

Polynovo (PNV)

AU ASX:PNV (1.4B)

2.19
0.00 (0.00%)
4pm Monday Aug 03 AEST
LOADING
Loading price chart..

Summary

Current Price: $2.19
52w High/Low: $1.25 - 3.285
Market Cap: 1.4B
Price/Earnings: -
Dividend Yield: -
Volume/Average: 3.8M - $980
Polynovo (ASX:PNV) Company Logo

Listed in 1998

PolyNovo develops and commercialises innovative medical devices using its NovoSorb technology in the treatment of burns, surgical wounds and Negative Pressure Wound Therapy.
Polynovo (ASX:PNV) Company Logo

PolyNovo develops and commercialises innovative medical devices using its NovoSorb technology in the treatment of burns, surgical wounds and Negative Pressure Wound Therapy.

Annual Reports

Annual Report FY19 and 4E Aug 21st 2019
2019
(4.3mb)
Amendment to Annual Report - Marketable Parcel Update Oct 12th 2018
2018
(2.4mb)
Annual Report to Shareholders and Appendix 4E Aug 16th 2018
2018
(2.0mb)
Annual Report to shareholders and Appendix 4E Aug 24th 2017
2017
(2.7mb)
Full Year Statutory Accounts and Appendix 4E Aug 22nd 2016
2016
(1.2mb)
Annual Report to shareholders Oct 29th 2015
2015
(1.3mb)

Dividend History

No dividends found.

Quantitative Ratios

Stock Ratios Locked
You viewed 3 companies today
Ratios will be unlocked
again tomorrow or;

Unlock these ratios,
configure alerts
and much more...

Download StockLight

All Ratios, Alerts and other features are available in our iOS and Android apps:
Download on iOS Download on Android

We are working on updating this web app to fully enable Quantitative Ratios. All other current web features including annual reports, price sensitive announcements, dividends and earnings transcripts are free to use here on our web app.
Dividend Yield
4.1%
 
0.0%
 
 
Industry Avg
PNV

UNATTRACTIVE: Polynovo's dividend yield of 0.0% is less than the industry average for health care equipment & services stocks listed on the ASX. more
Implied Growth
19.8%
 
10.5%
 
 
Industry Avg
PNV

ATTRACTIVE: Polynovo exhibits an implied growth ratio which is less than the industry average for health care equipment & services stocks listed on the ASX. PNV calculation: 10% - (-$0.01 / $2.19) = 10.5% more
Price / Book
5.7
 
59.0
 
 
Industry Avg
PNV

UNATTRACTIVE: Polynovo exhibits a price/book ratio which exceeds the industry average for health care equipment & services stocks listed on the ASX. more
Price / Sales
3.9
 
81.0
 
 
Industry Avg
PNV

UNATTRACTIVE: Polynovo exhibits a price/sales ratio which exceeds the industry average for health care equipment & services stocks listed on the ASX. more

Company News

These ASX medical shares fell double figures in July – are they a buy?
August 3rd, 2020 - Motley Fool

Investors in these two ASX medical shares have locked in recent gains sending prices down significantly. Are they worthy long-term buys? The post These ASX medical shares fell double figures in July – are they a buy? appeared first on Motley Fool Australia.

Why PolyNovo and these ASX healthcare shares could be long term market beaters
July 28th, 2020 - Motley Fool

PolyNovo Ltd (ASX:PNV) and these ASX healthcare shares could be long term markets beaters for Australian investors. Here's why... The post Why PolyNovo and these ASX healthcare shares could be long term market beaters appeared first on Motley Fool Australia.

3 junior ASX healthcare shares with explosive growth potential
July 27th, 2020 - Motley Fool

For investors wishing to diversity into the healthcare sector, but who also want to look beyond big names like Cochlear Limited and CSL Limited, here are 3 junior ASX healthcare shares with long growth runways ahead of them. The post 3 junior ASX healthcare shares with explosive growth potential appeared first on Motley Fool Australia.

Why Opthea shares could offer big growth potential
July 24th, 2020 - Motley Fool

Junior ASX healthcare company Opthea Ltd (ASX: OPT) has had a volatile year, but it could still be on the path to delivering substantial gains to long-term shareholders. The post Why Opthea shares could offer big growth potential appeared first on Motley Fool Australia.

Why the Polynovo share price could climb in August
July 23rd, 2020 - Motley Fool

The Polynovo Ltd (ASX: PNV) has had a strong year but I think it could push even higher after its August earnings result. The post Why the Polynovo share price could climb in August appeared first on Motley Fool Australia.

Why this underperforming ASX healthcare company could still light up the market in 2020 and beyond
July 23rd, 2020 - Motley Fool

Despite suffering through a lacklustre 2020, Medical Developments International Limited (ASX:MVP) could still have a long growth runway ahead of it. The post Why this underperforming ASX healthcare company could still light up the market in 2020 and beyond appeared first on Motley Fool Australia.

4 exciting ASX biotech shares surging higher today
July 21st, 2020 - Motley Fool

The ASX biotech segment has been on fire today. Here we take a closer look at 4 ASX biotech shares that have seen particularly strong share price gains today. The post 4 exciting ASX biotech shares surging higher today appeared first on Motley Fool Australia.

5 of the worst performing ASX shares from last week
July 20th, 2020 - Motley Fool

The S&P/ASX 200 Index (ASX: XJO) rose 1.9% last week to finish the week at 6033.6, having received a mid-week boost on hopes of a coronavirus vaccine. The post 5 of the worst performing ASX shares from last week appeared first on Motley Fool Australia.